Atezolizumab

Roche presents five-year survival outcomes for Tecentriq plus chemotherapy in ES-SCLC

Read more

Roche gets positive CHMP opinion for Tecentriq plus Avastin to treat liver cancer

Read more

Roche gets US FDA approval for Tecentriq combo to treat advanced melanoma

Read more

Roche’s Atezolizumab receives DCGI approval for treatment of metastatic triple-negative breast cancer in India

Read more

Roche’s Atezolizumab receives DCGI approval for small cell lung cancer treatment in India

Read more